KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Inventory Average (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Inventory Average for 14 consecutive years, with $80.9 million as the latest value for Q4 2025.

  • Quarterly Inventory Average rose 36.79% to $80.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.9 million through Dec 2025, up 36.79% year-over-year, with the annual reading at $68.3 million for FY2025, 3.78% up from the prior year.
  • Inventory Average for Q4 2025 was $80.9 million at Supernus Pharmaceuticals, up from $61.7 million in the prior quarter.
  • The five-year high for Inventory Average was $91.3 million in Q1 2023, with the low at $46.7 million in Q2 2025.
  • Average Inventory Average over 5 years is $72.3 million, with a median of $74.7 million recorded in 2021.
  • The sharpest move saw Inventory Average surged 93.06% in 2021, then crashed 34.76% in 2025.
  • Over 5 years, Inventory Average stood at $73.1 million in 2021, then rose by 19.57% to $87.4 million in 2022, then fell by 7.91% to $80.4 million in 2023, then fell by 26.49% to $59.1 million in 2024, then soared by 36.79% to $80.9 million in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $80.9 million, $61.7 million, and $46.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.